Our study identified a potential signaling pathway for CMs to communicate with fibroblasts during HF and a potential therapeutic approach for patients with chronic HF through downregulating FoxO6 expression in myocardial tissue. This evidence concerns the gene FOXO6 and hydrops fetalis.